Author

Mahmoud A Elhasab

lecturer assistant of medicinal chemistry, King Salman international University - Cited by 424 - Drug design - Molecular modeling and chemical synthesis

Biography

Dr. Mahmoud A Elhasab is currently working at Chemistry Department. Mahmoud A Elhasab is research interests includes Chemistry in Dynamic simulation. Mahmoud A Elhasab serving as an editorial member and reviewer of several international reputed journals. Mahmoud A Elhasab has successfully completed his Administrative responsibilities. Mahmoud A Elhasab has authored of many research articles/books related to Medicine.
Title
Cited by
Year
Development of isatin-thiazolo [3, 2-a] benzimidazole hybrids as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological and …
WM Eldehna, MA El Hassab, MF Abo-Ashour, T Al-Warhi, MM Elaasser, ...Bioorganic Chemistry 110, 104748, 2021202
40
2021
In silico identification of novel SARS-COV-2 2′-O-methyltransferase (nsp16) inhibitors: structure-based virtual screening, molecular dynamics simulation and MM-PBSA approaches
MA El Hassab, TM Ibrahim, ST Al-Rashood, A Alharbi, RO Eskandrani, ...Journal of enzyme inhibition and medicinal chemistry (1), 727-7, 2021202
36
2021
Identification of a New Potential SARS-COV-2 RNA-Dependent RNA Polymerase Inhibitor via Combining Fragment-Based Drug Design, Docking, Molecular …
MA El Hassab, AA Shoun, ST Al-Rashood, T Al-Warhi, WM EldehnaFrontiers in Chemistry 8, 584894, 2020202
34
2020
Identification of Novel Cyanopyridones and Pyrido[2,3-d]pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological …
T Al-Warhi, AAM Sallam, LR Hemeda, MA El Hassab, N Aljaeed, ...Pharmaceuticals 15 (10), 1262, 2022202
31
2022
Development of novel isatin–nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing–bacteria
ZM Elsayed, WM Eldehna, MM Abdel-Aziz, MA El Hassab, EB Elkaeed, ...Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 384-392, 2021202
27
2021
GC/MS Profiling, Anti-Collagenase, Anti-Elastase, Anti-Tyrosinase and Anti-Hyaluronidase Activities of a Stenocarpus sinuatus Leaves Extract
MM Younis, IM Ayoub, NM Mostafa, MA El Hassab, WM Eldehna, ...Plants 11 (7), 918, 2022202
27
2022
Multi-step in silico discovery of natural drugs against COVID-19 targeting main protease
EB Elkaeed, FS Youssef, IH Eissa, H Elkady, AA Alsfouk, ML Ashour, ...International Journal of Molecular Sciences 23 (13), 6912, 2022202
27
2022
Identification of potential inhibitors for HCV NS3 genotype 4a by combining protein–ligand interaction fingerprint, 3D pharmacophore, docking, and dynamic simulation
MAEM El-Hasab, EE El-Bastawissy, TF El-MoselhyJournal of Biomolecular Structure and Dynamics 36 (7), 1713-1727, 2018201
22
2018
Toward the identification of potential α-ketoamide covalent inhibitors for SARS-CoV-2 main protease: Fragment-based drug design and MM-PBSA calculations
MAE Hassab, M Fares, MKAH Amin, ST Al-Rashood, A Alharbi, ...Processes 9 (6), 1004, 2021202
19
2021
Direct acting anti-hepatitis C combinations as potential COVID-19 protease inhibitors
M Hamed, M El-Hasab, FR MansourVirusDisease 32 (2), 279-285, 2021202
17
2021
Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4, 5-dihydropyrazoles as anticancer agents with potential EGFR …
WM Eldehna, MA El Hassab, ZM Elsayed, T Al-Warhi, H Elkady, ...Scientific reports 12 (1), 12821, 2022202
15
2022
In silico identification of potential SARS COV-2 2′-O-methyltransferase inhibitor: fragment-based screening approach and MM-PBSA calculations
MA El Hassab, TM Ibrahim, AA Shoun, ST Al-Rashood, HM Alkahtani, ...RSC advances 11 (26), 16026-16033, 2021202
13
2021
Multi-stage structure-based virtual screening approach towards identification of potential SARS-CoV-2 NSP13 helicase inhibitors
MA El Hassab, WM Eldehna, ST Al-Rashood, A Alharbi, RO Eskandrani, ...Journal of enzyme inhibition and medicinal chemistry 37 (1), 563-572, 2022202
12
2022
Olive leaves as a potential phytotherapy in the treatment of COVID-19 disease; A Mini-Review
SM Abdelgawad, MAE Hassab, MAS Abourehab, EB Elkaeed, ...Frontiers in Pharmacology 13, 879118, 2022202
12
2022
Identification of potential inhibitors for HCV NS5b of genotype 4a by combining dynamic simulation, protein–ligand interaction fingerprint, 3D pharmacophore, docking and 3D QSAR
MAEM El-Hassab, EE El-Bastawissy, TF El-MoselhyJournal of Biomolecular Structure and Dynamics 38 (15), 4521-4535, 2020202
11
2020
Fenticonazole nitrate loaded trans-novasomes for effective management of tinea corporis: design characterization, in silico study, and exploratory clinical appraisal
R Albash, MH Ragaie, MAE Hassab, R El-Haggar, WM Eldehna, ...Drug Delivery 2 (1), 1100-1111, 2022202
9
2022
In silico approach using free software to optimize the antiproliferative activity and predict the potential mechanism of action of pyrrolizine-based Schiff bases
FA Almalki, AN Abdalla, AM Shawky, MA El Hassab, AM GoudaMolecules 26 (13), 4002, 2021202
8
2021
LC/MS analysis of Viscum cruciatum Sieber ex Boiss. Extract with anti-proliferative activity against MCF-7 cell line via G0/G1 cell cycle arrest: An in-silico and in-vitro study
LC/MS analysis of Viscum cruciatum Sieber ex Boiss. Extract with anti-proliferative activity against MCF- cell line via G0/G1 cell cycle arrest: An in-silico and in-vitro studyF Abo-Elghiet, MH Ibrahim, MA El Hassab, A Bader, QMA Abdallah, ...Journal of Ethnopharmacology 295, 115439, 2022202
7
2022
PHYTOCHEMICAL SCREENING AND BIOLOGICAL EVALUATION OF DYPSIS LEPTOCHEILOS LEAVES EXTRACT AND MOLECULAR DOCKING STUDY OF THE ISOLATED COMPOUNDS
EGH HAITHAM ALI IBRAHIM1*, FATEHIA SAYED ELSHARAWY1, MAHMMOUD ELHASSAB2 ...International Journal of Pharmacy and Pharmaceutical Sciences 12 (11), 2020202
7
2020
Development of potent nanosized isatin-isonicotinohydrazide hybrid for management of Mycobacterium tuberculosis
WM Eldehna, MA El Hassab, NA Abdelshafi, FAZ Sayed, M Fares, ...International Journal of Pharmaceutics 612, 121369, 2022202
7
2022

Referred From: https://scholar.google.com/citations?user=rd8_1qsAAAAJ&hl=en

Cited by
Citations 424
h-index 12
i10-index 15
Recommended Journals
Open Access Journals